Maria Maccecchini Annovis's guest appearances

Maria Maccecchini Annovis

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Maria Maccecchini

Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer's, Parkinson's and other neurodegenerative diseases by tapping into the brain's defense mechanism to get rid of toxic proteins that impair axonal transport, the body's information highway. Affecting the manufacture of amyloid, tau and alpha-synuclein, the treatment is lowering inflammation and showing statistical improvement in function. #Alzheimers #Parkinsons #axonaltransport Annovisbio.com Download the transcript here

Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer's, Parkinson's and other neurodegenerative diseases by tapping into the brain's defense mechanism to get rid of toxic proteins that impair axonal transport, the body's information highway. Affecting the manufacture of amyloid, tau and alpha-synuclein, the treatment is lowering inflammation and showing statistical improvement in function. #Alzheimers #Parkinsons #axonaltransport <a href="http://annovisbio.com" rel="noopener nofollow" target="_blank">Annovisbio.com</a> <a href="http://empoweredpatientradio.com/treating-alzheimers-and-parkinsons-by-addressing-axonal-transport-to-protect-nerve-cells-from-dying-with-maria-maccecchini-annovis-bio-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Treating Alzheimer’s and Parkinson’s by Addressing Axonal Transport  to Protect Nerve Cells from Dying with Maria Maccecchini Annovis Bio